Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideABTAbbott Laboratories
FinDog View：Neutral
TMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | ABT | TMO |
|---|
| Close | 102.36 | 648.43 |
| Market Cap | $177B | $240B |
| 1M | −7.26% | +10.75% |
| P/E (TTM) | 33.2 | 34.4 |
| Forward P/E | 18.1 | 21.8 |
| P/E 5-Yr Percentile | 66 | 65 |
| P/S | 3.9 | 5.2 |
| P/B | 3.5 | 4.6 |
| Dividend Yield | 1.98% | 0.29% |
| Latest Quarter Revenue | $11.2B | $12.0B |
| Revenue YoY | +7.8% | +10.5% |
| Gross Margin | 56.2% | — |
| Latest Quarter EPS | 0.61 | 4.68 |
| Avg Post-Earnings Move | ±1.6% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.81% | 2.36% |
| 90-Day Net Insider Buying | −$46.7M | −$38.9M |
ABT · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
